OECD Home › Innovation › Innovation in science, technology and industry › Latest Documents
Using two waves of the Community Innovation Survey (CIS) for the Netherlands, this paper integrates recent lines of research to estimate the contribution of innovation to manufacturing multifactor productivity (MFP) growth.
While patent data are now readily available for most nations, these data are still of minimal use for economic analysis. The OECD Technology Concordance (OTC) presented in this paper allows researchers to transform IPC-based patent data into patent counts by sector of the economy.
Services are the driving force in OECD economies, accounting for at least 70% of GNP in many countries. However, their potential contribution is hampered by government policies that were designed for manufacturing industries.
This study investigates the long-term effects of various types of R&D on multifactor productivity growth, which is the spillover effect of R&D. Econometric estimates are conducted on a panel of 16 OECD countries, over the period 1980-98. All results are averages over countries and time.
Science and technology improves human health but the pressure for faster and larger improvements is increasing in this area. A fundamental starting point for better understanding the impact of innovation on health is the measurement of research and development.
English, , 61kb
The purpose of the present chapter is to describe the flow of employees into and out of the higher educational system from and into the surrounding economy.
This paper compares venture capital activity across OECD countries by taking into account international venture capital flows.
Achieving sustainable development goals at a global level will strongly depend on the rapid development and widespread application of cleaner technologies. But do developing countries have the capacity and motivation to take advantage of cleaner technology options?
This working paper summarises the information gathered by the OECD Secretariat as part of its work to obtain an accurate assessment of the current state of biotechnology statistics in OECD member and observer countries.
This document attempts to quantify the aggregate net effect of government funding on business R&D in 17 OECD member countries over the past two decades.